Oppenheimer & Co »

Avadel Pharmaceuticals shares owned by Oppenheimer & Co

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Oppenheimer & Co from 13F filings

Historical chart of Oppenheimer & Co investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Oppenheimer & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $434k 33k 13.12

More positions owned by Oppenheimer & Co

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)

View all positions for Oppenheimer & Co

Top funds holding Avadel Pharmaceuticals

Henderson Group
Jeffrey L. Gendell
BlackRock
BlackRock
Vanguard Group
Braidwell
Citadel Advisors
Wealth Effects
Two Seas Capital
Vestal Point Capital
Woodline Partners
Brandes Investment Partners
Tang Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Avadel Pharmaceuticals